Article citationsMore>>

Heier, J.S., Khanani, A.M., Quezada Ruiz, C., Basu, K., Ferrone, P.J., Brittain, C., et al. (2022) Efficacy, Durability, and Safety of Intravitreal Faricimab up to Every 16 Weeks for Neovascular Age-Related Macular Degeneration (TENAYA and LUCERNE): Two Randomised, Double-Masked, Phase 3, Non-Inferiority Trials. The Lancet, 399, 729-740.
https://doi.org/10.1016/s0140-6736(22)00010-1

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top